TRAX

First Tracks Biotherapeutics, Inc.

Healthcare · Biotechnology · —

34.40$ -3.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Cash Flow TRAX
Line item	2023	2024	2025
Operating Cash Flow	-2.68	-3.62	-4.11
Depreciation & Amortization	0.07	0.07	0.07
Stock-Based Compensation	0.53	0.77	0.93
Change in Working Capital	0.08	0.55	-0.04
Capital Expenditures	0.02	0.01	0.00
Investing Cash Flow	4.17	2.75	6.56
Financing Cash Flow	-2.51	3.38	0.86
Change in Cash	-1.02	2.51	3.31
Free Cash Flow	-2.70	-3.63	-4.12

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.